Sansure Biotech Inc.

Informe acción SHSE:688289

Capitalización de mercado: CN¥13.9b

Sansure Biotech Dirección

Dirección controles de criterios 3/4

El CEO de Sansure Biotech es Lizhong Dai, nombrado en Jul 2019, tiene una permanencia de 5.33 años. posee directamente un 33.21% de las acciones de la empresa, con un valor de CN¥4.63B. La antigüedad media del equipo directivo y de la junta directiva es de 5.3 años y 5.3 años, respectivamente.

Información clave

Lizhong Dai

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO5.3yrs
Participación del CEO33.2%
Permanencia media de la dirección5.3yrs
Promedio de permanencia en la Junta Directiva5.3yrs

Actualizaciones recientes de la dirección

Recent updates

Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Nov 03
Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Oct 09
Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Oct 03
Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sep 12
Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Aug 21
Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Jun 03
Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

May 03
Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Apr 26
Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

Feb 28
Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

CEO

Lizhong Dai (56 yo)

5.3yrs

Permanencia

CN¥991,000

Compensación

Mr. Lizhong Dai is Chairman of the Board and General Manager of Sansure Biotech Inc. from July 2019.


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Lizhong Dai
Chairman of the Board & GM5.3yrsCN¥991.00k33.21%
CN¥ 4.6b
Peng Zhu
CFO, Deputy GM5.3yrsCN¥1.14m0.067%
CN¥ 9.3m
Xialin Yu
Deputy GM & Director5.3yrsCN¥675.40k0.026%
CN¥ 3.7m
Xu Fan
Deputy GM & Director5.3yrsCN¥1.07m0.054%
CN¥ 7.5m
Jia Liu
Deputy GM & Directorno dataCN¥1.03m0.035%
CN¥ 4.9m
Zhongping Deng
Deputy General Manager5.8yrsCN¥973.70k0.019%
CN¥ 2.6m
Jun Zhou
Deputy General Manager5.3yrsCN¥1.11m0.016%
CN¥ 2.2m
Liu Kai
Deputy General Manager3.3yrsCN¥1.90m0.026%
CN¥ 3.6m
Jian Zhu
Deputy General Manager3.3yrsCN¥3.05m0.025%
CN¥ 3.4m
Haixiao Wang
Deputy General Manager2.3yrsCN¥2.15m0.041%
CN¥ 5.7m
Xiaoyan Xiong
Deputy General Manager2.1yrsCN¥868.70k0.022%
CN¥ 3.1m

5.3yrs

Permanencia media

47yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 688289 es experimentado (5.3 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Lizhong Dai
Chairman of the Board & GM5.3yrsCN¥991.00k33.21%
CN¥ 4.6b
Peng Zhu
CFO, Deputy GM4.8yrsCN¥1.14m0.067%
CN¥ 9.3m
Xialin Yu
Deputy GM & Director5.3yrsCN¥675.40k0.026%
CN¥ 3.7m
Xu Fan
Deputy GM & Director4.1yrsCN¥1.07m0.054%
CN¥ 7.5m
Jia Liu
Deputy GM & Director2.3yrsCN¥1.03m0.035%
CN¥ 4.9m
Wu Tan
Chairman of Supervisory Board5.3yrssin datos0.035%
CN¥ 4.9m
Ya Cao
Independent Director5.3yrsCN¥75.00ksin datos
Yuan Fang
Director5.3yrssin datossin datos
Ling Lin
Supervisor2.3yrssin datos0.00040%
CN¥ 55.7k

5.3yrs

Permanencia media

45yo

Promedio de edad

Junta con experiencia: La junta directiva de 688289 se considera experimentada (5.3 años de antigüedad promedio).